The deferiprone controversy: time to move on.
Naylor
C David
CD
Faculty of Medicine, University of Toronto, Ont.
D000046:Academic Medical Centers; D002986:Clinical Trials as Topic / Q000009:adverse effects; D016265:Conflict of Interest; D000077543:Deferiprone; D004992:Ethics, Medical; D006776:Hospitals, Pediatric; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects*; D009864:Ontario; D011728:Pyridones / Q000009:adverse effects*; D015871:Scientific Misconduct
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone